Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV and Monthly Update - November 2020

7 Jan 2021 07:00

RNS Number : 8355K
Honeycomb Investment Trust PLC
07 January 2021
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

7 January 2021

Honeycomb Investment Trust plc

Honeycomb Investment Trust plc (the "Company") announces that the Investment Manager's monthly factsheet for 30 November 2020 is now available on its website at http://www.honeycombplc.com.

Net Asset Value per Share

The Company announces that its unaudited Net Asset Value ("NAV") per share as at 30 November 2020 on a cum-income basis was 1,006.4 pence, based on a NAV of £354.9 million, and on an ex-income basis was 1,017.9 pence, based on a NAV of £358.9 million. The NAVs have been calculated by Apex Fund Services (UK) Ltd.

November Factsheet

Honeycomb Investment Trust plc (the "Company") delivered a NAV return of 0.62% for the month, which is equivalent to 7.5% per annum. The portfolio continues to perform well with NAV returns rising to pre-Covid-19 levels.

 

The Manager deployed £30m of investment into Credit Assets over the course of November including the acquisition of a portfolio of performing short term real estate loans. This increased the investment portfolio to £576.9m.

The larger investment portfolio has increased returns with NAV return for November at 7.5% per annum. The investment yield was 9.7% per annum with a modest impairment charge of 0.3% per annum. The low impairment charge reflects the increasing proportion of structurally secured loans, which given the seniority, generally have lower impairments and the low levels of new forbearance requests. Third party servicing costs remain at 0.6% per annum. This is expected to reduce over time as the Company reduces its exposure to consumer direct and reduces the corresponding service charge.

Buybacks

 

In November the Company repurchased 210,000 of its shares at an average price of 922.7p. The total buybacks year to date now total 4,190,178 or 10.6% of the share capital. The Company has reduced the level of buybacks recently as the share price has performed well.

 

 

 

 

This document is made available for information purposes only and does not contain any representations or constitute an offer to sell or the solicitation of an offer to acquire or subscribe for any securities of the Company. All investments are subject to risk. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate and past performance is no guarantee of future results. 

For further information about this announcement please contact:

Pollen Street Capital - Investment Manager

Matthew Potter / Julian Dale: +44 (0)20 3728 6750

Liberum Capital Limited - Joint Broker

Chris Clarke / Louis Davies: +44 (0)20 3100 2000 

Cenkos Securities plc - Joint Broker

Justin Zawoda-Martin / Rob Naylor: +44 (0)20 7397 8900

Link Company Matters Limited - Corporate Secretary

Paul Johnston: +44 (0)20 7954 9552

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVGZGGMNVNGMZM
Date   Source Headline
27th Jan 20206:26 pmRNSResult of Buy-Back and total voting rights
27th Jan 20204:08 pmRNSProposed Share Trade and Share Buy-Back
23rd Jan 20207:01 amRNSMonthly Update - December 2019
23rd Jan 20207:00 amRNSNet Asset Value(s)
20th Dec 20197:01 amRNSMonthly Update - November 2019
20th Dec 20197:00 amRNSNet Asset Value(s)
16th Dec 20191:51 pmRNSResult of General Meeting
29th Nov 20197:00 amRNSCircular and Notice of General Meeting
27th Nov 20197:01 amRNSMonthly Update - October 2019
27th Nov 20197:00 amRNSNet Asset Value(s)
19th Nov 20194:13 pmRNSHolding(s) in Company
8th Nov 20197:00 amRNSDividend Declaration
21st Oct 20197:01 amRNSMonthly Update - September 2019
21st Oct 20197:00 amRNSNet Asset Value(s)
30th Sep 20197:01 amRNSMonthly Update - August 2019
30th Sep 20197:00 amRNSNet Asset Value(s)
10th Sep 20197:00 amRNSHalf-year Report 2019
5th Sep 20193:02 pmRNSDividend Declaration
21st Aug 20197:01 amRNSMonthly Update - July 2019
21st Aug 20197:00 amRNSNet Asset Value(s)
12th Aug 20192:51 pmRNSPublication of Suppl.Prospcts
7th Aug 20195:13 pmRNSDirector/PDMR Shareholding
25th Jul 20197:01 amRNSMonthly Update - June 2019
25th Jul 20197:00 amRNSNet Asset Value(s)
25th Jun 201910:10 amRNSMonthly Update - 31 May 2019
25th Jun 201910:04 amRNSNet Asset Value(s)
14th Jun 20197:00 amRNSDirectorate Change
6th Jun 20195:33 pmRNSResult of AGM
21st May 20197:01 amRNSMonthly Update - 30 April 2019
21st May 20197:00 amRNSNet Asset Value(s)
3rd May 20192:46 pmRNSNotice of Annual Report & Director Resignation
29th Apr 20197:00 amRNSDividend Declaration
29th Apr 20197:00 amRNSAnnual Report and Audited Financial Statements
26th Apr 20197:01 amRNSMonthly Update - 31 March 2019
26th Apr 20197:00 amRNSNet Asset Value(s)
21st Mar 20197:01 amRNSMonthly Update - 28 February 2019
21st Mar 20197:00 amRNSNet Asset Value(s)
22nd Feb 20197:02 amRNSMonthly Update - 31 January 2019
22nd Feb 20197:01 amRNSDividend Declaration
22nd Feb 20197:00 amRNSNet Asset Value(s)
29th Jan 20197:01 amRNSFact Sheet December 2018
29th Jan 20197:00 amRNSNet Asset Value(s)
21st Dec 201812:49 pmRNSPlacing Programme: publication of prospectus
21st Dec 20187:01 amRNSMonthly Update - 30 November 2018
21st Dec 20187:00 amRNSNet Asset Value - 30 November 2018
22nd Nov 20187:01 amRNSMonthly Update - 31 October 2018
22nd Nov 20187:00 amRNSNet Asset Value - 31 October 2018
16th Nov 20187:00 amRNSDividend Declaration
23rd Oct 20187:01 amRNSMonthly Update - 30 September 2018
23rd Oct 20187:00 amRNSNet Asset Value - 30 September 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.